S.Biomedics Co., Ltd.

304360· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩20,100+4.74%

2026-11-02

Financials

Valuation Metrics

S.Biomedics Co., Ltd.'s Market Cap is ₩2509B. At end of 2025 it was ₩4737B. Ranked #712 of 2,410 in KR market (top 30%), #304 of 1,631 on KOSDAQ (top 19%), #76 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 33%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	250.87B KRW	KR#712/2,410 Sec#76/231
Revenue	16.49B KRW	KR#2,186/2,410 Sec#162/231
Net Income	-10.70B KRW	KR—/2,410 Sec—/231
Total Assets	37.49B KRW	KR#2,290/2,410 Sec#210/231
Net Assets	16.71B KRW	KR#2,321/2,410 Sec#219/231
Employees	54	KR#2,015/2,410 Sec#185/231
Value
P/B	15.01x	KR#2,385/2,410 Sec#220/231
P/S	15.21x	KR#2,314/2,410 Sec#178/231
FCF Yield	-3.33%	KR—/2,410 Sec—/231
Profitability
ROE	-64.00%	KR#2,298/2,410 Sec#206/231
ROA	-28.53%	KR#2,300/2,410 Sec#199/231
Op. Margin	-68.42%	KR#2,258/2,410 Sec#165/231
Revenue Growth	-3.53%	KR#1,703/2,410 Sec#164/231
Financial Health
Debt Ratio	124.30%	KR#1,740/2,410 Sec#194/231
Total Debt	11.88B KRW	KR#1,563/2,410 Sec#139/231
FCF	-8.35B KRW	KR#1,648/2,410 Sec#138/231
Cash	4.85B KRW	KR#2,010/2,410 Sec#187/231
Performance
1Y Return	-14.65%	KR#1,024/2,410 Sec#65/231
1M Return	-3.83%	KR#977/2,410 Sec#97/231
From 52W High	-52.82%	KR#1,372/2,410 Sec#111/231
1Y MDD	-62.67%	KR#1,591/2,410 Sec#129/231
Trading
Volume	10,840 shares	KR#1,542/2,410 Sec#159/231
Trading Value	211.2M KRW	KR#922/2,410 Sec#102/231
Foreign Own.	2.05%	KR#1,601/2,410 Sec#153/231
Per Share
EPS	-857 KRW	KR—/2,410 Sec—/231
BPS	1,339 KRW	KR#2,234/2,410 Sec#199/231

Company Info

CEO 강세일

Employees 54

Founded 2003

HQ 서울특별시 성동구, KR

Website www.sbiomedics.com/

동사는 2003년 설립 후 2005년 줄기세포치료제 개발 사업으로 전환했으며, 종속회사 에스테팜은 2016년 설립되어 필러와 화장품을 제조·판매하고 있음. 동사는 줄기세포 분화기술과 3차원 세포집합체 기술을 활용해 다양한 질환 영역에서 세포치료제를 개발 중임. 배아줄기세포를 이용한 치료제는 세계적으로 드물어 주요국들과 경쟁하며 차별화된 생산기술로 임상 성공 가능성을 높이고 있음. 에스바이오메딕스는 2003년에 설립되었으며 서울특별시 성동구에 본사를 두고 있습니다.